These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6762375)

  • 1. Phospholipid bilayer permeability of beta-lactam antibiotics.
    Yamaguchi A; Hiruma R; Sawai T
    J Antibiot (Tokyo); 1982 Dec; 35(12):1692-9. PubMed ID: 6762375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of Yersinia kristensenii strains to beta-lactam antibiotics.
    Bejar V; Calvo C; Ramos Cormenzana A
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):169-77. PubMed ID: 3501272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bacterial outer-membrane permeability of beta-lactam antibiotics.
    Sawai T; Matsuba K; Tamura A; Yamagishi S
    J Antibiot (Tokyo); 1979 Jan; 32(1):59-65. PubMed ID: 368002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible role of R plasmids in bacterial permeability for beta-lactam antibiotics.
    Ikeuchi T; Osada Y
    Microbiol Immunol; 1981; 25(4):333-44. PubMed ID: 7019627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
    Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cephalosporinases from Bacteroides fragilis, Bacteroides thetaiotaomicron and Bacteroides vulgatus.
    Sato K; Matsuura Y; Miyata K; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1983 Jan; 36(1):76-85. PubMed ID: 6332105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics.
    Coulton JW; Mason P; Dorrance D
    J Antimicrob Chemother; 1983 Nov; 12(5):435-49. PubMed ID: 6608514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of cephalosporinase from Proteus morganii.
    Toda M; Inoue M; Mitsuhashi S
    J Antibiot (Tokyo); 1981 Nov; 34(11):1469-75. PubMed ID: 6976340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae.
    Jarlier V; Gutmann L; Nikaido H
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1937-9. PubMed ID: 1952873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of Aeromonas hydrophila to beta-lactam antibiotics.
    Zemelman R; Gonzalez C; Mondaca MA; Silva J; Merino C; Dominguez M
    J Antimicrob Chemother; 1984 Dec; 14(6):575-9. PubMed ID: 6335147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental studies on the passage of antibiotics into cerebrospinal fluid in staphylococcal meningitis in rabbits. II. Cephaloridine, cephalothin and cefazolin (author's transl)].
    Morikawa Y; Haruta T; Fujiwara T; Kobayashi Y
    Jpn J Antibiot; 1978 Jun; 31(6):325-33. PubMed ID: 682368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipopolysaccharide barrier: correlation of antibiotic susceptibility with antibiotic permeability and fluorescent probe binding kinetics.
    Snyder DS; McIntosh TJ
    Biochemistry; 2000 Sep; 39(38):11777-87. PubMed ID: 10995246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response profiles: A method of evaluating the activity of beta-lactam antibiotics against Enterobacteria.
    Greenwood D
    Chemotherapy; 1977; 23(1):11-8. PubMed ID: 318970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-factor mediated beta-lactamase production by Haemophilus influenzae.
    Sykes RB; Matthew M; O'Callaghan CH
    J Med Microbiol; 1975 Aug; 8(3):437-41. PubMed ID: 1080810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic antibiotics for women undergoing vaginal hysterectomy.
    Lett WJ; Ansbacher R; Davison BL; Otterson WN
    J Reprod Med; 1977 Aug; 19(2):51-4. PubMed ID: 330851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo comparative evaluations of injectable cephalosporin derivatives and ampicillin.
    Gotô S; Kuwahara S
    Chemotherapy; 1976; 22(5):286-96. PubMed ID: 1047636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of 5 beta-lactam antibiotics to beta-lactamase isolated from E. coli and its respective transconjugates].
    Galante D; Esposito S; Barba D; Scioli C
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1678-82. PubMed ID: 6320847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.